azilsartan
Also known as TAK 536, TAK-536, TAK536
Azilsartan, sold under the brand name Edarbi among others, is used for the treatment of hypertension. It is used as the prodrug azilsartan medoxomil, is an angiotensin II receptor antagonist, and was developed by Takeda.
Key facts
- Drug.legal_status
- Rx-only
- Drug.bioavailability
- 60%
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 456077928
- Drug.image
- Azilsartan.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- Edarbi, Azilva
- Drug.MedlinePlus
- a611028
- Drug.DailyMedID
- Azilsartan
- Drug.routes_of_administration
- By mouth
- Drug.ATC_prefix
- C09
- Drug.ATC_suffix
Article
9 sectionsContents
- Medical uses
- Contraindications
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Chemistry
- History
- References
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 456077928 | image = Azilsartan.svg | image_class = skin-invert-image | width = | alt = | caption = | USAN =
| pronounce = | tradename = Edarbi, Azilva | Drugs.com = | MedlinePlus = a611028 | DailyMedID = Azilsartan | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = C09 | ATC_suffix = CA09 | ATC_supplemental =
Gallery (2)
Connections
Categories
Angiotensin II receptor antagonistsBenzimidazolesBiphenylsCarbamatesChemical articles with multiple CAS registry numbersChemical articles with multiple ChEBIsChemical articles with multiple PubChem CIDsChemical pages without DrugBank identifierChemicals using indexlabelsCombination antihypertensive drugsDrugboxes which contain changes to verified fields